Endogenous sex hormones and C‐reactive protein in healthy postmenopausal women
Open Access
- 8 August 2008
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 264 (3) , 245-253
- https://doi.org/10.1111/j.1365-2796.2008.01946.x
Abstract
: Background. Oral oestrogen replacement therapy increases levels of C‐reactive protein (CRP). CRP is an established strong predictor of cardiovascular events. It is unknown whether endogenous oestrogen levels are associated with CRP. We therefore studied the relationship between endogenous sex hormones and CRP in healthy postmenopausal women emphasizing the role of body composition as peripheral fat is both a main source of oestrogen production after menopause and an endocrine tissue with inflammatory activities.Subjects and methods. The study population comprised 889 women participating in the PROSPECT study, an ongoing population‐based cohort study. Information on risk factors was collected by questionnaires and clinical examination. Endogenous sex hormone levels and CRP were measured with double antibody radio immuno assay (RIA) from fasting plasma samples. In this cross‐sectional study, associations between risk factors and lnCRP were studied using linear regression models.Results. Increases in oestrone and free oestradiol levels and the free androgen index were related to an increase in lnCRP of 1.19, 1.23 and 1.21 mg dL−1 respectively. Body mass index (BMI), waist circumference and physical activity were strongly related to CRP levels, independent of age and other cardiovascular risk factors. Levels of all sex steroids but dehydroepiandrostenedione decreased with age. In age‐adjusted analyses, an increase in waist circumference or BMI by one quartile was associated with a 1.28‐fold and 1.26‐fold increase in CRP. The relationship between endogenous hormones and CRP was modestly attenuated but remained highly significant after adjustment for body composition, physical activity and other traditional cardiovascular risk factors.Conclusions. Our findings show that in postmenopausal women high levels of endogenous oestrogenic and androgenic sex steroids coincide with high CRP levels. This was only explained in part by markers of body composition or intra‐abdominal fat.Keywords
This publication has 28 references indexed in Scilit:
- Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic reviewFertility and Sterility, 2008
- Mechanisms linking obesity with cardiovascular diseaseNature, 2006
- Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal womenActa Endocrinologica, 2006
- Association of Endogenous Hormones with C-reactive Protein, Fibrinogen, and White Blood Count in Post-menopausal WomenEuropean Journal of Epidemiology, 2005
- Sex Hormone-Binding Globulin and Serum Testosterone are Inversely Associated with C-Reactive Protein Levels in Postmenopausal Women at High Risk for Cardiovascular DiseaseAnnals of Epidemiology, 2005
- Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older womenAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Androgens and AntiandrogensAnnals of the New York Academy of Sciences, 2003
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperaturePublished by Elsevier ,2003
- Inflammation in atherosclerosisNature, 2002
- Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connectionMedical Hypotheses, 2001